NDT Pharmaceuticals Inc. (NDTP)
OTCMKTS · Delayed Price · Currency is USD
0.9900
+0.1200 (13.79%)
At close: Feb 11, 2026
NDT Pharmaceuticals Market Cap
NDT Pharmaceuticals has a market cap or net worth of $145.73 million as of February 12, 2026. Its market cap has increased by 22,535.78% in one year.
Market Cap
145.73M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.99
Market Cap Chart
Since October 21, 2011, NDT Pharmaceuticals's market cap has increased from 2.76M to 145.73M, an increase of 5,181.59%. That is a compound annual growth rate of 31.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 145.73M | -44.69% |
| Dec 31, 2025 | 263.50M | 3,007.18% |
| Dec 31, 2024 | 8.48M | -13.47% |
| Dec 28, 2023 | 9.80M | 1,785.32% |
| Dec 31, 2021 | 519.82K | -69.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 413.38M |
| CytoDyn | 304.50M |
| Silence Therapeutics | 224.36M |
| Vaxart | 145.67M |
| HST Global | 139.70M |
| BioStem Technologies | 113.23M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |